This MRFR report offers a detailed analysis of the Global Dermal Fillers Market along with a six-year (2017-2023) revenue projection. It also includes a thorough observation of the pertinent market elements such as drivers, restraints, opportunities and challenges. A revenue analysis based on different types of dermal fillers such as hyaluronic acid, collagen, botulinum toxin and polymers & particles is also available in the research document. The application areas for dermal fillers considered in the report include lip treatments, facial line correction treatment and face-lift.
There is a growing market for facial injectables – popularly known as dermal fillers in various parts of the world. The latest study conducted by Market Research Future (MRFR) projects that the global market for dermal fillers will surpass a valuation of US$ 10000 million by the year 2023, exhibiting a compound annual growth rate of 12.5% between 2017 and 2023. Increased acceptance of such products is creating lucrative opportunities for market players. The growing demand for facial aesthetics across the globe is a major force driving the growth of the global dermal fillers market. More and more people are opting for cosmetic procedures to maintain a youthful look. As the standard of living rises around the world, beauty enhancing services including dermal filler procedures become more popular.
To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/3893
October 03, 2018 – Allergan, Inc. (Ireland), a leading global leader in developing, manufacturing and commercializing branded pharmaceuticals, devices, biologics, surgical and regenerative medicine products launched a new advertising campaign for its product – JUVÉDERM which is a dermal filler collection.
- Dr. Korman Laboratories (Israel),
- GALDERMA (Switzerland),
- ALLERGAN (Republic of Ireland),
- Merz Pharma (Germany),
- Teoxane laboratories (Switzerland),
- Sinclair Pharma (UK), and
- Integra Lifesciences (US).
The highly competitive market of dermal fillers appears to be diversified with the presence of a large number of players having a global presence. These players are adopting strategic initiatives such as expansion, and product Launch to gain the competitive edge and are tapping the growing markets for expansions.
Leverage to the rising cases of side effects or resistance, players are focusing on innovative products and procedures that would have minimal adverse effects. Also, growth opportunities in the market are encouraging these players to target emerging applications.
MRFR’s report includes a descriptive segmental analysis of dermal fillers market based on types and application. By types, the market has been segmented into botulinum toxin, hyaluronic acid, polymers & particles and collagen. Among these, the botulinum toxin segment is likely to remain the most profitable segment. The segment is expected to reach a market valuation in excess of US$ 4600 by 2023-end. Meanwhile, the hyaluronic acid segment is projected to record the fastest growth rate during the assessment period.
By application, the market has been segmented into lip treatments, facial line correction treatment, face-lift and others. In 2016, the facial line correction treatment segment commanded the largest market share and is expected to reach a valuation of over US$ 4300 Mn by the year 2023. The face-lift segment is also expected to remain highly attractive in 2018 and beyond. The segment is expected to capture a robust CAGR of 12.8% between 2017 and 2023.
Geographically, North American regions account for the leading market for dermal fillers followed by the European and Asia Pacific region, respectively. The dermal fillers market in this region is heading with the support of the US market which is growing significantly backed by the high spending and growing uptake of dermal fillers.
In 2016, the US dermal fillers market had valued at USD 1,074.0 MN. witnessing, substantial investments in R&D activities and technologically advanced products. The dermal fillers market in North America is expected to reach over 3,700 Mn. USD by 2023.
The European region, accounting for the second-largest market for dermal fillers witnesses a substantial growth due to high per capita income and strong healthcare penetration in the region. The strong market growth in countries such as Germany & France drives the growth of the regional market to an extent. Backed by the wide uptake of new products and advanced therapies, the European dermal fillers market is estimated to evaluate at 10,000 MN USD by 2023.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/dermal-fillers-market-3893
The dermal fillers market in the Asia Pacific region has emerged as one of the promising markets, globally. Factors such as spreading awareness towards these aesthetic treatments, and improving per capita income are substantiating the market growth. India and China backed by the ever-increasing population, economic growth, and the burgeoning medical treatment market account for the major contributing economies across the region.
Furthermore, South East Asian countries such as Vietnam, Malaysia, and Thailand are significantly contributing to the growth of the regional market with their burgeoning medical tourism markets
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312